Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Non-cash Items: 2018-2024

Historic Non-cash Items for Revolution Medicines (RVMD) over the last 7 years, with Dec 2024 value amounting to $118.8 million.

  • Revolution Medicines' Non-cash Items rose 47.10% to $177.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $177.7 million, marking a year-over-year increase of 47.10%. This contributed to the annual value of $118.8 million for FY2024, which is 3.30% up from last year.
  • Revolution Medicines' Non-cash Items amounted to $118.8 million in FY2024, which was up 3.30% from $115.0 million recorded in FY2023.
  • Revolution Medicines' Non-cash Items' 5-year high stood at $165.1 million during FY2020, with a 5-year trough of $84.0 million in FY2021.
  • Over the past 3 years, Revolution Medicines' median Non-cash Items value was $115.0 million (recorded in 2023), while the average stood at $106.3 million.
  • In the last 5 years, Revolution Medicines' Non-cash Items spiked by 221.96% in 2020 and then tumbled by 49.15% in 2021.
  • Over the past 5 years, Revolution Medicines' Non-cash Items (Yearly) stood at $165.1 million in 2020, then crashed by 49.15% to $84.0 million in 2021, then rose by 1.46% to $85.2 million in 2022, then skyrocketed by 35.02% to $115.0 million in 2023, then rose by 3.30% to $118.8 million in 2024.